Laura Ottini


Titolo Pubblicato in Anno
HER2-Low Expression in Male Breast Cancer: Results from a Multicenter Series in Italy CANCERS 2024
Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond CANCERS 2024
Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology FRONTIERS IN ONCOLOGY 2023
Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study EUROPEAN JOURNAL OF CANCER 2023
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants JOURNAL OF CLINICAL ONCOLOGY 2022
Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19 MICROORGANISMS 2022
Reply to V. Fallet et al JOURNAL OF CLINICAL ONCOLOGY 2022
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care CANCERS 2022
A possible link between gut microbiome composition and cardiovascular comorbidities in psoriatic patients JOURNAL OF PERSONALIZED MEDICINE 2022
Gut microbiome profile in psoriatic patients treated and untreated with biologic therapy JOURNAL OF DERMATOLOGY 2021
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers NATURE COMMUNICATIONS 2021
Bone density and genomic analysis unfold cold adaptation mechanisms of extinct inhabitants of Tierra del Fuego SCIENTIFIC REPORTS 2021
Pre-diagnostic DNA methylation patterns differ according to mammographic breast density amongst women who subsequently develop breast cancer: a case-only study in the EPIC-Florence cohort BREAST CANCER RESEARCH AND TREATMENT 2021
Transcriptome of male breast cancer matched with germline profiling reveals novel molecular subtypes with possible clinical relevance CANCERS 2021
DNA methylation-based biomarkers of aging were slowed down in a two-year diet and physical activity intervention trial: the DAMA study AGING CELL 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores JOURNAL OF THE NATIONAL CANCER INSTITUTE 2021
Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families JOURNAL OF CLINICAL ONCOLOGY 2020
Matched germline and tumor profiling in male breast cancer for the discovery of molecular subtypes with clinical relevance Cancer ResearchCANCER RESEARCH 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants JAMA ONCOLOGY 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma